Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Alzheimer's disease using specific medical guidelines (called IWG-2 2014 criteria)
- You are between 50 and 90 years old
- You are covered by a social security or health insurance scheme
- You scored 20 or above on a standard memory and thinking test called the MMSE
- Your spinal fluid (collected via a lumbar puncture) shows abnormal levels of certain Alzheimer's-related proteins called Aβ42 or Aβ40/Aβ42, based on your local lab's standards
- Your spinal fluid also shows abnormal levels of proteins called phosphorylated Tau and total Tau, based on your local lab's standards
- You are able to take part in memory and thinking (neuropsychological) tests
- You have had a brain MRI scan (including a specific type called a T1 volumetric sequence) within the last year
Who may not be able to join:
- You have been diagnosed with a different type of dementia or memory condition (other than Alzheimer's disease)
- You are currently taking part in another clinical trial testing a treatment for Alzheimer's disease
- You are a protected adult, including anyone under a court-ordered guardianship arrangement
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emmanuel GOGNAT, MD, PhD, Assistance Publique - Hôpitaux de Paris
Phone: + 1 44 08 33 81
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean levels of new blood biomarkers
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.